Streetbeat News

Regulatory

TKNO

Alpha Teknova, Inc. (NASDAQ:TKNO) has announced the opening of a new GMP-certified production facility in Hollister, California. The facility, which recently received ISO 13485:2016 certification, will increase the company's manufacturing capacity for custom, high-quality life sciences reagents. The new facility will enable bioprocessing and gene therapy companies to get into the clinic faster.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:25 pm

GOOG

GOOGL

Google, a subsidiary of Alphabet Inc., has proposed to the Australian government that copyright laws should be altered to allow AI systems to gather data from the internet, while providing an opt-out option for publishers who wish to keep their content untouched. This proposal was made in response to a review of AI regulations by the Australian government. The proposed system would be similar to the current 'robots.txt' method, which allows website owners to prevent search engines from accessing parts of their site.

Portfolio Pulse from Sudhanshu Singh

August 09, 2023 | 12:25 pm

DARE

Daré Bioscience has announced positive preliminary efficacy results from its Phase 1/2 clinical study of DARE-HRT1, a treatment for menopausal symptoms, in healthy postmenopausal women. The study found that DARE-HRT1 demonstrated preliminary treatment efficacy for both Vasomotor Symptoms (VMS) and Genitourinary Syndrome of Menopause (GSM). Daré plans to advance DARE-HRT1 into a single Phase 3 efficacy trial for the treatment of VMS due to menopause. If successful, DARE-HRT1 could be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:24 pm

ELTX

Elicio Therapeutics (NASDAQ:ELTX) has published preclinical data demonstrating that its AMP-CpG adjuvant can induce a potent and durable immune response to Epstein-Barr virus (EBV). The data shows that AMP-CpG directed the trafficking of the vaccine adjuvant into the lymph node to increase the potency of subunit vaccines for inducing T-cells and neutralizing antibodies. The company's near-term focus remains progressing ELI-002, its cancer vaccine candidate for mutant KRAS-driven solid tumors, through the ongoing phase 1 trials and to a randomized trial in pancreatic cancer in 2024.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:23 pm

DBDQQ

Diebold Nixdorf, currently trading under the symbol DBDQQ, is expected to emerge from financial restructuring on August 11 and be relisted on the NYSE on August 14.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:11 pm

PALI

Palisade Bio announced that its study did not achieve the primary efficacy endpoint of reducing adhesions in LB1148 treated patients compared to placebo treated patients post bowel resection surgery.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:07 pm

DZSI

DZS Inc. has reported a delay in the filing of its Q2 10-Q due to an ongoing review by the Audit Committee. This review is connected to the restatement of previously issued unaudited condensed consolidated financial statements for the three months ended March 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:07 pm

OCX

Oncocyte has regained compliance with Nasdaq's listing requirements, potentially avoiding delisting.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:03 pm

EWJ

FXI

China is planning to lift its ban on group travel to Japan as early as Thursday, according to Nikkei. This could potentially boost tourism and related sectors in Japan.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:56 am

AAPL

GOOG

MSFT

SPOT

WMG

Google and Universal Music are discussing licensing artists' melodies and voices for AI-generated songs to counter the rise of 'deepfake' songs. They are exploring a partnership to develop a tool that allows fans to create AI-generated tracks and pay copyright owners. Warner Music Group has also discussed a similar product with Google. Universal Music has urged Spotify and Apple to restrict access to its music catalog for AI technology training. Google's interest in AI-generated songs aligns with its competition against Microsoft, which has invested in AI company OpenAI.

Portfolio Pulse from Anusuya Lahiri

August 09, 2023 | 11:56 am